研究表明,智能吸入器可大大促进青蒿素综合症患者和哮喘患者的药物坚持使用。 Study shows smart inhalers significantly boost medication adherence for COPD and asthma patients.

Adherium Limited与Intermountain健康和CareCentra合作进行的一项新研究显示,对患有青蒿素综合症和哮喘的病人的药物遵守情况有了显著改善。 A new study by Adherium Limited, in partnership with Intermountain Health and CareCentra, shows significant improvements in medication adherence for patients with COPD and asthma. 研究利用智能吸入器发现,病人使用吸入器的时间几乎占其时间的三分之二,而通常使用1/5的比例。 Using smart inhalers, the study found patients used their inhalers almost two-thirds of the time, compared to the usual one-in-five rate. 一半以上的病人在一年多的时间里仍然使用远程监测系统。 Over half of the patients remained engaged with the remote monitoring system for over a year. 本研究报告强调了数字保健工具在改善患者结果方面的潜力,并提出了可持续的护理模式。 This study highlights the potential of digital health tools to improve patient outcomes and suggests a sustainable care model.